Tuberculosis associated with tumor necrosis factor-α antagonists, case description and analysis of reported cases in Colombia

Tumor necrosis factor-α (TNF-α) is an important fundamental cytokine during the immune response against cancer and infections such as tuberculosis. This molecule also plays a key pathogenic role in complex and difficult-to-treat diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn’s...

Full description

Bibliographic Details
Published in:Biomédica
Main Authors: Leandro Galvis, Ángel Y. Sánchez, Leonardo F. Jurado, Martha I. Murcia
Format: Article in Journal/Newspaper
Language:English
Spanish
Published: Instituto Nacional de Salud 2018
Subjects:
R
Online Access:https://doi.org/10.7705/biomedica.v38i0.3273
https://doaj.org/article/2476996fa15c4f2ab6ca6bed8d7dc8b5
Description
Summary:Tumor necrosis factor-α (TNF-α) is an important fundamental cytokine during the immune response against cancer and infections such as tuberculosis. This molecule also plays a key pathogenic role in complex and difficult-to-treat diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, psoriasis and ulcerative colitis. The treatment of these diseases frequently needs TNF-α antagonists, which has been related to an increased risk of developing tuberculosis, mycoses, and other severe infections. We report the case of a 68-year-old man with Crohn’s disease, who developed disseminated tuberculosis due to anti-TNF-α immunosuppressive therapy. The diagnosis was based on the histopathological findings and molecular biology assays. We discuss the clinical presentation and workup of this case, and we present a comparative analysis of tuberculosis cases associated with anti-TNF-α reported in Colombia during the last 10 years emphasizing on the diagnosis and treatment of latent tuberculosis.